Amlodipine Besylate
Product Images NDC 54868-5764

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 54868-5764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 5 mg Package Label (5761)

Image Of 5 mg Package Label (5761)
This is a label information of a medication named Amlodipine Besylate SHG, distributed by Physicians Total Care. It has a National Drug Code (NDC) of 54868-5761-8 and lot number of 0060 with an expiration date of 01/60. The rest of the information is not readable.*
FDA Label Image

Image Of 10 mg Package Label (5762)

Image Of 10 mg Package Label (5762)
The text seems to be a label of a medicine named "Amlodipine Besylate" with a strength of 10mg per tablet. The medicine may be related to the treatment or management of certain health conditions, but the specific details are not available from the given text. The label also mentions "Physicians Total Care" as the manufacturer or supplier of the medicine.*
FDA Label Image

Image Of 2.5 mg Package Label (5764)

Image Of 2.5 mg Package Label (5764)
AMLODIPINE BESYLATE is a medication used to treat high blood pressure and chest pain. The text also mentions the dosage of 2.5mg as well as the form of the medication being tablets. However, due to the garbled and misread characters in the text, some information may be inaccurate.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
FDA Label Image

Image Of Figure 2 (Figure 2)

Image Of Figure 2 (Figure 2)
This data appears to be from a study involving patients with an unspecified condition and analyzing the effect of Amlodipine versus a placebo. The patients were characterized by various factors such as gender, baseline sitting SEP, and baseline vessel disease. The study also mentions the PCI-stent strategies employed. However, there is not enough information to infer the results or conclusions of the study. The only conclusive data is that the mean sitting baseline SBP was 120 mmbg.*
FDA Label Image
Image Of Glenmark Logo (Logo)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.